| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 0 | $0 | $54.31 | 09 Dec 2025 | Direct |
| Akero Therapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 0 | 09 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | 09 Dec 2025 | 13 | $0 | 4 | Chief Scientific Officer | 09 Dec 2025, 10:14 |
| AKRO | Akero Therapeutics, Inc. | 25 Nov 2025 | 12 | +$624,087 | 4 | Chief Scientific Officer | 28 Nov 2025, 06:03 |
| AKRO | Akero Therapeutics, Inc. | 17 Nov 2025 | 1 | $0 | 4 | Chief Scientific Officer | 19 Nov 2025, 20:04 |
| AKRO | Akero Therapeutics, Inc. | 07 Oct 2025 | 4 | -$221,626 | 4 | Chief Scientific Officer | 09 Oct 2025, 18:58 |
| AKRO | Akero Therapeutics, Inc. | 11 Sep 2025 | 1 | -$23,790 | 4 | Chief Scientific Officer | 12 Sep 2025, 20:36 |
| AKRO | Akero Therapeutics, Inc. | 08 Sep 2025 | 8 | -$362,371 | 4 | Chief Scientific Officer | 10 Sep 2025, 19:48 |
| AKRO | Akero Therapeutics, Inc. | 05 Aug 2025 | 4 | -$352,674 | 4 | Chief Scientific Officer | 07 Aug 2025, 09:00 |
| AKRO | Akero Therapeutics, Inc. | 07 Jul 2025 | 5 | -$375,036 | 4 | Chief Scientific Officer | 09 Jul 2025, 19:00 |
| AKRO | Akero Therapeutics, Inc. | 30 Jun 2025 | 1 | +$21,243 | 4 | Chief Scientific Officer | 02 Jul 2025, 18:00 |
| AKRO | Akero Therapeutics, Inc. | 18 Jun 2025 | 1 | -$61,914 | 4 | Chief Scientific Officer | 20 Jun 2025, 21:07 |
| AKRO | Akero Therapeutics, Inc. | 10 Jun 2025 | 1 | -$127,323 | 4 | Chief Scientific Officer | 12 Jun 2025, 18:33 |
| AKRO | Akero Therapeutics, Inc. | 05 Jun 2025 | 9 | -$1,253,630 | 4 | Chief Scientific Officer | 09 Jun 2025, 17:30 |
| AKRO | Akero Therapeutics, Inc. | 06 May 2025 | 5 | -$279,114 | 4 | Chief Scientific Officer | 08 May 2025, 19:34 |
| AKRO | Akero Therapeutics, Inc. | 24 Apr 2025 | 4 | -$124,562 | 4 | Chief Scientific Officer | 28 Apr 2025, 18:22 |
| AKRO | Akero Therapeutics, Inc. | 07 Apr 2025 | 6 | -$92,386 | 4 | Chief Scientific Officer | 10 Apr 2025, 18:00 |
| AKRO | Akero Therapeutics, Inc. | 12 Mar 2025 | 1 | -$23,158 | 4 | Chief Scientific Officer | 14 Mar 2025, 20:18 |
| AKRO | Akero Therapeutics, Inc. | 05 Mar 2025 | 4 | -$292,840 | 4 | Chief Scientific Officer | 07 Mar 2025, 17:30 |
| AKRO | Akero Therapeutics, Inc. | 05 Feb 2025 | 4 | -$664,005 | 4 | Chief Scientific Officer | 07 Feb 2025, 18:05 |
| AKRO | Akero Therapeutics, Inc. | 27 Jan 2025 | 7 | -$1,102,016 | 4 | Chief Scientific Officer | 29 Jan 2025, 20:43 |
| AKRO | Akero Therapeutics, Inc. | 07 Jan 2025 | 1 | $0 | 4 | Chief Scientific Officer | 10 Jan 2025, 19:38 |
| AKRO | Akero Therapeutics, Inc. | 26 Dec 2024 | 1 | $0 | 4 | Chief Scientific Officer | 30 Dec 2024, 20:20 |
| AKRO | Akero Therapeutics, Inc. | 16 Dec 2024 | 5 | -$42,666 | 4 | Chief Scientific Officer | 18 Dec 2024, 20:52 |
| AKRO | Akero Therapeutics, Inc. | 10 Dec 2024 | 4 | -$100,253 | 4 | Chief Scientific Officer | 12 Dec 2024, 20:44 |
| AKRO | Akero Therapeutics, Inc. | 10 Sep 2024 | 1 | -$14,059 | 4 | Chief Scientific Officer | 13 Sep 2024, 17:11 |
| AKRO | Akero Therapeutics, Inc. | 28 Jun 2024 | 1 | +$21,217 | 4 | Chief Scientific Officer | 02 Jul 2024, 18:57 |
| AKRO | Akero Therapeutics, Inc. | 11 Jun 2024 | 1 | -$53,886 | 4 | Chief Scientific Officer | 13 Jun 2024, 18:06 |
| AKRO | Akero Therapeutics, Inc. | 13 Mar 2024 | 1 | -$17,536 | 4 | Chief Scientific Officer | 15 Mar 2024, 16:42 |
| AKRO | Akero Therapeutics, Inc. | 14 Dec 2023 | 1 | -$10,671 | 4 | Chief Scientific Officer | 18 Dec 2023, 20:29 |
| AKRO | Akero Therapeutics, Inc. | 08 Dec 2023 | 2 | $0 | 4 | Chief Scientific Officer | 12 Dec 2023, 16:38 |
| AKRO | Akero Therapeutics, Inc. | 13 Sep 2023 | 1 | -$26,731 | 4 | Chief Scientific Officer | 25 Sep 2023, 21:30 |
| AKRO | Akero Therapeutics, Inc. | 16 Jun 2023 | 5 | -$4,259,666 | 4 | Chief Scientific Officer | 21 Jun 2023, 17:46 |
| AKRO | Akero Therapeutics, Inc. | 13 Jun 2023 | 1 | -$28,076 | 4 | Chief Scientific Officer | 15 Jun 2023, 21:35 |
| AKRO | Akero Therapeutics, Inc. | 10 Mar 2023 | 1 | -$26,212 | 4 | Chief Scientific Officer | 14 Mar 2023, 16:19 |
| AKRO | Akero Therapeutics, Inc. | 28 Dec 2022 | 7 | -$852,347 | 4 | Chief Scientific Officer | 30 Dec 2022, 15:26 |
| AKRO | Akero Therapeutics, Inc. | 16 Dec 2022 | 1 | $0 | 4 | Chief Scientific Officer | 20 Dec 2022, 18:47 |
| AKRO | Akero Therapeutics, Inc. | 09 Dec 2022 | 2 | $0 | 4 | Chief Scientific Officer | 13 Dec 2022, 19:30 |
| AKRO | Akero Therapeutics, Inc. | 15 Nov 2022 | 3 | -$320,806 | 4 | Chief Scientific Officer | 16 Nov 2022, 18:15 |
| AKRO | Akero Therapeutics, Inc. | 25 Oct 2022 | 6 | -$591,666 | 4 | Chief Scientific Officer | 27 Oct 2022, 21:27 |
| AKRO | Akero Therapeutics, Inc. | 06 Oct 2022 | 3 | -$673,125 | 4 | Chief Scientific Officer | 07 Oct 2022, 18:00 |
| AKRO | Akero Therapeutics, Inc. | 30 Sep 2022 | 6 | -$1,143,811 | 4 | Chief Scientific Officer | 04 Oct 2022, 20:57 |
| AKRO | Akero Therapeutics, Inc. | 13 Sep 2022 | 3 | -$592,950 | 4/A | Chief Scientific Officer | 27 Oct 2022, 21:23 |
| AKRO | Akero Therapeutics, Inc. | 09 Sep 2022 | 4 | +$30,488 | 4 | Chief Scientific Officer | 13 Sep 2022, 21:14 |
| AKRO | Akero Therapeutics, Inc. | 08 Dec 2021 | 1 | $0 | 4 | Chief Scientific Officer | 10 Dec 2021, 16:07 |